Wegovy (semaglutide 2.4 mg) is the only semaglutide product FDA-approved for chronic weight management, and its mechanism of action, reducing hunger at the hormonal level, is exactly what sedentary professionals need
Nicholas Thomson, Ph.D
The Weight Watchers difference: At 6 months, our Med+ members on the GLP-1 Success Program lost 27 lbs, on average.^ ^Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program
This treatment is commonly used to restore energy, improve mental clarity, and support healthy metabolism
Dive into wellness, wherever you are
[DOI] [PMC free article] [PubMed] [Google Scholar] 101.Yoon H.Y., Kang N.I., Lee H.K., Jang K.Y., Park J.W., Park B.H